Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Martijn Bos

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
European Heart Journal|February 25, 2011
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathyJonathan N Johnson, Camilla Grifoni, J Martijn Bos, et al.
Circulation. Genomic and Precision Medicine|August 21, 2019
Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel PerturbationSteven I Estes, Dan Ye, Wei Zhou, et al.
The Annals of Thoracic Surgery|April 13, 2019
Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality?Anita Nguyen, Hartzell V Schaff, Rick A Nishimura, et al.
Circulation. Arrhythmia and Electrophysiology|August 9, 2015
Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac DeathNicole J Boczek, Dan Ye, Fang Jin, et al.
Circulation. Genomic and Precision Medicine|May 30, 2020
Corrected QT Interval-Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family MembersKari L Turkowski, Steven M Dotzler, David J Tester, et al.
Journal of Cardiovascular Translational Research|February 26, 2016
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic CardiomyopathySinead L Murphy, Jason H Anderson, Jamie D Kapplinger, et al.
European Heart Journal|September 11, 2014
Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia riskRachel M A ter Bekke, Kristina H Haugaa, Arthur van den Wijngaard, et al.
Journal of the American College of Cardiology|December 11, 2020
Echocardiography-Guided Risk Stratification for Long QT SyndromeAlan Sugrue, Martin van Zyl, Nick Enger, et al.
Plos One|June 29, 2017
MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathyJames W McNamara, Amy Li, Sean Lal, et al.
Journal of Cardiovascular Electrophysiology|January 7, 2015
Effects on repolarization using dynamic QT interval monitoring in long-QT patients following left cardiac sympathetic denervationChristopher V Desimone, J Martijn Bos, Katy M Bos, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
European Heart Journal|February 25, 2011
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathyJonathan N Johnson, Camilla Grifoni, J Martijn Bos, et al.
Circulation. Genomic and Precision Medicine|August 21, 2019
Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel PerturbationSteven I Estes, Dan Ye, Wei Zhou, et al.
The Annals of Thoracic Surgery|April 13, 2019
Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality?Anita Nguyen, Hartzell V Schaff, Rick A Nishimura, et al.
Circulation. Arrhythmia and Electrophysiology|August 9, 2015
Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac DeathNicole J Boczek, Dan Ye, Fang Jin, et al.
Circulation. Genomic and Precision Medicine|May 30, 2020
Corrected QT Interval-Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family MembersKari L Turkowski, Steven M Dotzler, David J Tester, et al.
Journal of Cardiovascular Translational Research|February 26, 2016
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic CardiomyopathySinead L Murphy, Jason H Anderson, Jamie D Kapplinger, et al.
European Heart Journal|September 11, 2014
Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia riskRachel M A ter Bekke, Kristina H Haugaa, Arthur van den Wijngaard, et al.
Journal of the American College of Cardiology|December 11, 2020
Echocardiography-Guided Risk Stratification for Long QT SyndromeAlan Sugrue, Martin van Zyl, Nick Enger, et al.
Plos One|June 29, 2017
MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathyJames W McNamara, Amy Li, Sean Lal, et al.
Journal of Cardiovascular Electrophysiology|January 7, 2015
Effects on repolarization using dynamic QT interval monitoring in long-QT patients following left cardiac sympathetic denervationChristopher V Desimone, J Martijn Bos, Katy M Bos, et al.
Pageof 17